Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China [Phase 3]

View source ↗

Summary

A Phase 3 trial in China evaluating duloxetine for chronic pain due to osteoarthritis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)
  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-23